The innovative drug sector fluctuated and declined. Jiankai Technology and Wanbang Pharmaceutical fell more than 13%, while Longshen Rongfa, Xidian Pharmaceutical, Hanson Pharmaceuticals, Watson Biotech, Shanghai Yizhong, Sanyuan Gene, and Weikang Pharmaceutical had the highest declines.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.